Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Weekly
Analytics
Project Updates and Milestones news
10 March 2026
INA Completes Rijeka Refinery Upgrade
The Rijeka Refinery upgrade boosts capacity, reduces import reliance, and enhances energy security. A green hydrogen plant is planned, with completion expected by 2026.
10 March 2026
KT-Kinetics Technology Completes Rijeka Refinery Upgrade Project
The project included a new delayed coking unit and process revamp, overcoming challenges like COVID-19 and geopolitical issues, with a ceremony attended by key officials.
10 March 2026
RWE Sells Polish Offshore Wind Project to PGE
PGE acquires 350 MW F.E.W. Baltic II project and Environmental Decision for site 44.E.1. RWE continues to support Poland's energy transition with onshore wind and solar projects.
10 March 2026
RWE and Vestas Finalize Turbine Deal for Vanguard East Wind Farm
92 turbines to power Vanguard East, with commissioning in 2030. Final investment decision expected in summer 2026. Project to supply electricity to 1.5 million UK homes.
10 March 2026
Covestro and Fraunhofer UMSICHT Launch Smart Pyrolysis Pilot for Foam Recycling
A 2kt/year pilot plant will recycle polyurethane foam into high-purity aniline for MDI, reducing carbon footprint by up to 40%. Operational by 2028, it targets hard-to-recycle rigid foam.
10 March 2026
ORLEN Confirms Gas Discovery in North Sea's Sleipner Area
Gas and condensate found in Frida Kahlo prospect, estimated at 7.2 million barrels. Production to start by 2026 using existing infrastructure, reducing costs and time.
News type
New Projects and Expansions
New Projects and Expansions
Project Updates and Milestones
Project Updates and Milestones
Mergers, Acquisitions, and Partnerships
Mergers, Acquisitions, and Partnerships
Innovation and Product Development
Innovation and Product Development
Operational Changes and Investments
Operational Changes and Investments
Sustainability and Environmental Initiatives
Sustainability and Environmental Initiatives
Financial Performance and Strategy
Financial Performance and Strategy
Executive Appointments and Governance Changes
Executive Appointments and Governance Changes
Regulatory and Compliance Updates
Regulatory and Compliance Updates
Workforce and Corporate Social Responsibility (CSR)
Workforce and Corporate Social Responsibility (CSR)
Crisis and Risk Management
Crisis and Risk Management
The right choices in the European chemical industry
Save time with
chemXplore Analytics
Learn more
10 March 2026
Equinor Finds Oil and Gas in North Sea
Oil and gas found in Troll and Sleipner areas, leveraging existing infrastructure. New discoveries support ongoing energy supply and exploration efforts on the Norwegian continental shelf.
10 March 2026
Aramco Reports Q4 and FY 2025 Financial Results
Strong 2025 financials: $104.7B net income, $85.4B free cash flow, 3.8% gearing. $85.5B shareholder distributions, AI-driven $5.3B value, 70% localization, gas expansion on track.
9 March 2026
MOL Group and JANAF Begin 10-Month Adria Pipeline Capacity Tests
The Adria pipeline undergoes 10-month tests to assess transport performance, logistics, and capacity, involving international experts. Results aim to resolve capacity debates by 2027.
9 March 2026
Infineum Opens New Blending Facility in India
The new facility in Patalganga enhances supply reliability, supports local manufacturing, and aligns with India's growth and sustainability goals.
8 March 2026
Genentech Updates on Phase III persevERA Study in ER-Positive Breast Cancer
persevERA study showed no significant progression-free survival improvement, but giredestrant was well tolerated. Further studies planned with CDK4/6 inhibitors.
6 March 2026
TotalEnergies Releases Independent Review of Tilenga Project Land Acquisition in Uganda
The assessment confirms compliance with land acquisition standards. An action plan addresses livelihood restoration, support for vulnerable households, grievance management, and gender considerations.
6 March 2026
Gasunie 2025 Report: Advancing Resilient and Sustainable Energy Systems
Invested €1.2B in energy security and transition. Hydrogen, CO2 projects near completion. Net profit rose to €85M. Gas transport up, especially to power stations.
5 March 2026
Johnson & Johnson's TECVAYLI and DARZALEX FASPRO Approved by FDA for Relapsed Multiple Myeloma
FDA approves TECVAYLI plus DARZALEX FASPRO for relapsed multiple myeloma, offering a new treatment option as early as second line with improved safety and efficacy.
5 March 2026
Genentech Reports Positive Phase II Results for Petrelintide in Obesity Treatment
Petrelintide shows significant weight loss and good tolerability in Phase II trial, supporting further development for chronic weight management.
5 March 2026
RWE Adds 2 GW to U.S. Energy Capacity
RWE completed 15 projects in 2025, adding solar, wind, and battery storage across seven U.S. states, creating 3,500 jobs and investing over $500 million in local communities.
4 March 2026
Topsoe's 2025 Financial Results Meet Expectations in Tough Market
Revenue reached DKK 8,197 million. EBIT margin at 8.9%. SAF projects in China. New CEO from March 2026. 2026 outlook: revenue DKK 7,600-8,400 million, EBIT margin 0.0-5.0%.
4 March 2026
thyssenkrupp Uhde's EnviNOx® Cuts Nitrous Oxide Emissions at CSBP
EnviNOx® tech reduces N₂O emissions by 98% at CSBP's nitric acid plants, aiding WesCEF's 2030 emissions goals and supporting decarbonization in agriculture and mining.
4 March 2026
NEXTCHEM Secures €485M Contract for Hydrogen, Ammonia, Urea, and Methanol Technologies in West Africa
The project includes hydrogen, ammonia, and urea units across three sites. Engineering has begun, with €10M recognized pre-FID.
4 March 2026
Sinopec Backs New National Greenhouse Gas Emission Database
The updated database includes methane emission factors for onshore facilities, aiding accurate greenhouse gas calculations and supporting emission reduction efforts in the oil and gas sector.
3 March 2026
Johnson & Johnson's Nipocalimab Gets FDA Fast Track for Lupus Treatment
Nipocalimab, an investigational therapy, aims to address unmet needs in lupus by reducing harmful IgG while preserving immune function, following positive Phase 2b results.
3 March 2026
Equinor Investigates Deepsea Bollsta Well Control Incident
A gas leak on Deepsea Bollsta was contained in 30 minutes. Safety systems worked, preventing escalation. Measures are in place to avoid recurrence.
3 March 2026
RIFT Secures €114M to Scale Iron Fuel Technology
€113.8M funding will develop a commercial iron fuel facility, aiming to decarbonize industrial heat and avoid over 1M tonnes of CO₂ emissions. Operational by 2029.
2 March 2026
Takeda's Rusfertide Receives FDA Priority Review
Rusfertide shows promise in controlling hematocrit and reducing symptoms in polycythemia vera, with FDA review based on positive Phase 3 and long-term study data.
2 March 2026
Equinor's Rapid Development Plan for Snorre Oil Discovery
New oil discovery in Snorre area to be quickly developed using existing infrastructure, reducing costs and environmental impact, while supporting European energy security.
2 March 2026
thyssenkrupp Uhde to Study Biomass-to-Methanol Integration for Nova Sustainable Fuels in Canada
The study will assess the integration of gasification and methanol synthesis to produce 450,000 metric tons of bio-methanol annually, aiding decarbonization in transportation and shipping.
2 March 2026
Galp 4Q & FY25 Financial Results
Strong 2025 performance with €2.2bn cash generation, 4% DPS increase, and €250m buyback. Key growth in Brazil, Namibia, and Sines. Net debt at €1.3bn, FCF at €81m.
1 March 2026
Genentech's Fenebrutinib Shows Promise as BTK Inhibitor for MS in Phase III Study
Fenebrutinib reduced relapses by 51% in RMS, consistent with prior studies. Data will be submitted to regulators. Safety profile comparable to teriflunomide; further analysis on fatalities ongoing.
28 February 2026
Merck and Eisai: WELIREG and LENVIMA Reduce Disease Progression Risk by 30% in Advanced RCC Trial
Phase 3 trial shows WELIREG plus LENVIMA improves progression-free survival in advanced RCC, with FDA reviewing new drug applications.
27 February 2026
FDA Approves Novo Nordisk's Sogroya for New Pediatric Uses
Sogroya, a once-weekly growth hormone, is now approved for children with ISS, SGA, or NS, offering an alternative to daily injections and expanding treatment options.
Next →
